placeholder image
T. R. Wassenaar All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Validation of immunotherapy response score as predictive of pan-solid tumor anti-PD-1/PD-L1 benefit
    Cancer Res Commun. 2023
  • Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: results of PrE0102
    Journal of Clinical Oncology. 2018
  • Contact
    full name
  • T. R. Wassenaar
  • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration